Skip Navigation

Cardiovascular Research 1998 40(2):307-313; doi:10.1016/S0008-6363(98)00126-6
© 1998 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Suzuki, J.-i.
Right arrow Articles by Sekiguchi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suzuki, J.-i.
Right arrow Articles by Sekiguchi, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1998, European Society of Cardiology

Sensitive diagnosis of cardiac allograft rejection by detection of cytokine transcription in situ

Jun-ichi Suzuki, Mitsuaki Isobe*, Satoshi Yamazaki, Shiro Horie, Yoshio Okubo and Morie Sekiguchi

The First Department of Internal Medicine, School of Medicine, Shinshu University, Matsumoto, Japan

* Corresponding author. Tel.: +81 (263) 372630; Fax: +81 (263) 363722; E-mail: isobemi@gipac.shinshu-u.ac.jp

Objective: In situ transcription of cytokines which are important in the development of cardiac rejection has not been evaluated for diagnosing rejection. The objective was to evaluate the usefulness of in situ reverse transcriptase polymerase chain reaction (RT-PCR) for sensitive detection of acute cardiac rejection. Methods: We studied interferon (IFN)-{gamma} and interleukin (IL)-2 expression using immunohistochemistry and in situ RT-PCR in murine cardiac transplant models. Hearts were heterotopically transplanted (BALB/c to C3H/He) and some mice were not treated (n=23); others were treated with anti-intercellular adhesion molecule (ICAM)-1 and anti-lymphocyte function associated antigen (LFA)-1 monoclonal antibodies (mAbs) (n=23). Allografts were removed at days 1 to 7. For control, isografts were harvested at day 7 (n=2). Results: Mice without treatment rejected allografts within 7 days, while all mAb-treated recipients accepted allografts for the same period. At day 1, allografts of both groups showed scattered myocardial cell infiltration which increased in non-treated allografts, but remained stable in mAb-treated grafts thereafter. In situ RT-PCR showed that IL-2 and IFN-{gamma} mRNA positive cells were present in non-treated allografts, while few mRNA positive cells were expressed in infiltrating cells in the mAb-treated allografts (IL-2, day 3: 88.8±28.3 vs. 7.2±6.4, p<0.05, positive cells within 10 fields per section). However, immunohistochemistry could not reveal the difference at day 3. Conclusion: In situ RT-PCR is a sensitive method for diagnosing acute rejection, and it reveals the characteristics of myocardial infiltrate cells to determine their role in the process of rejection.

KEYWORDS Mouse; Heart transplant; Rejection; Cytokine; Transcription


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Am. J. Pathol.Home page
B. M. Spriewald, M. Hara, A. Bushell, S. Jenkins, P. J. Morris, and K. J. Wood
Differential Role for Competitive Reverse Transcriptase-Polymerase Chain Reaction and Intracellular Cytokine Staining as Diagnostic Tools for the Assessment of Intragraft Cytokine Profiles in Rejecting and Nonrejecting Heart Allografts
Am. J. Pathol., November 1, 2000; 157(5): 1453 - 1458.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.